Federal · forecast · RFA-CA-28-001 · ALN 93.394

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health · HHS

This opportunity is not listed as open to nonprofits. Check the eligible applicants below before you apply.

Your odds: program 93.394

A realistic target for an established nonprofit. 16% of awards go to first-time applicants and nonprofits win 20%.

Based on 608 new awards in FY2023–25. The median award is $1,016,300. Expect about 262 days between posting and deadline.

First-time winners
16%
of new 93.394 awards
Nonprofit share
20%
of awards
Median award
$1.0M
FY2025
New awards, FY2025
172
608 in 3 years
Typical window
262 d
usually posts Dec
Under-$1M orgs
n/a
of nonprofit awards

Full history for 93.394 Cancer Detection and Diagnosis Research: past winners, past rounds, where the money goes

Est. deadline
To be announced
Posted
Jul 14, 2026
Cost sharing
Not required

How to apply

Read the full announcement on Grants.gov before you start. Federal applications are submitted through Grants.gov (or the agency's own system) and require a Unique Entity ID from SAM.gov. Registration can take several weeks, so start early.

View on Grants.gov

What are the odds for a first-time applicant?

A realistic target for an established nonprofit. 16% of awards go to first-time applicants and nonprofits win 20%. Based on 608 new awards in FY2023–25. The median award is $1,016,300. Expect about 262 days between posting and deadline.

Who can apply for Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)?

See the official announcement for eligibility details.

When is the deadline?

The funder has forecast this opportunity but hasn't announced a deadline yet. Sign up for a reminder and we'll email you when it opens.

Email me matching grants